Yourway Mitigates Uncertainty of Brexit
Yourway, courier and clinical packager offering integrated clinical trial supply chain solutions, announced its establishment of a new location within the European Union providing storage and distribution services, including secondary packaging capabilities, located 40 minutes from the Vienna, Austria airport in Bratislava, Slovakia. This move was designed to ensure uninterrupted support for clients’ trials in both the UK and mainland Europe if the United Kingdom leaves the EU on the current deadline of October 31, especially in the event of a no-deal Brexit.
“The new location in Europe mitigates the uncertainty of Brexit for our clients, in order to service their clinical trial needs. It includes Qualified Person (QP) release services within Europe prior to release for use in a Clinical Trial, as required by Clinical Trial Directive 2001/20/EC and Annex 13 to the European GMP Guide.” said Yourway President and Founder, Gulam Jaffer.
“Through our Project Managers and QP release personnel, and use of our global network of GMP depots, we can assure safe and timely delivery of clinical trial materials to patients,” he added.
Yourway provides a full range of temperature-controlled solutions designed to protect clinical trial shipments from the time an order is received through to delivery on time for patient dosing protocols. It is also offering an integrated supply chain with no differences in quality to traditional multi-provider models in this market.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
